Featured Stories

News
Hotspotting Program Yields More Disappointment, Officials Press On
January 24, 2020
Despite more disappointing study results on hotspotting—a cost reduction program focused on superutilizers—health officials believe the concept is still worth exploring.
News
Epizyme Prices Rare Tissue Cancer Treatment at $15,500 a Month
January 24, 2020
After receiving FDA approval, Epizyme releases pricing information for its rare tissue cancer drug, Tazverik.
News
CMS to Cover New Chronic Lower Back Pain Therapy
January 23, 2020
Earlier this week, CMS finalized a decision to cover a potential pain treatment for low back pain as an alternative to opioids.
News
ACP Publishes Support of Single-Payer System
January 22, 2020
The American College of Physicians recently shared its vision for an improved United States health care system and offered its support of a single-…
News
Single-Payer System Could Reduce Health Care Expenditures
January 21, 2020
Data shows that a single-payer system has the potential to reduce health care expenditures despite criticism that it would raise costs.
News
Chargemaster Pricing for Treatments May Be Misleading
January 16, 2020
A JAMA Oncology study shows that hospital list pricing posted online, which is referred to as a chargemaster, is often significantly different than…
News
CVS Health Publishes Methods to Reduce Gene Therapy Costs
January 16, 2020
In a recent white paper, CVS Health outlined four strategies that could improve patient access and care, as well as lead to significant payer cost…
Back to Top